L264-1285 Screening compound: N-[5-(4-ethoxybenzenesulfonamido)-1,3-benzothiazol-2-yl]-4-methylbenzamide

L264-1285 Screening compound: N-[5-(4-ethoxybenzenesulfonamido)-1,3-benzothiazol-2-yl]-4-methylbenzamide
L264-1285 Screening compound: N-[5-(4-ethoxybenzenesulfonamido)-1,3-benzothiazol-2-yl]-4-methylbenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L264-1285
N-[5-(4-ethoxybenzenesulfonamido)-1,3-benzothiazol-2-yl]-4-methylbenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L264-1285

Molecular Formula

C23H21N3O4S2 (C23 H21 N3 O4 S2)

Compound Name

N-[5-(4-ethoxybenzenesulfonamido)-1,3-benzothiazol-2-yl]-4-methylbenzamide

IUPAC name

N-[5-(4-ethoxybenzenesulfonamido)-13-benzothiazol-2-yl]-4-methylbenzamide

SMILES

CCOc(cc1)ccc1S(Nc(cc1)cc2c1sc(NC(c1ccc(C)cc1)=O)n2)(=O)=O

InChI

InChI=1S/C23H21N3O4S2/c1-3-30-18-9-11-19(12-10-18)32(28,29)26-17-8-13-21-20(14-17)24-23(31-21)25-22(27)16-6-4-15(2)5-7-16/h4-14,26H,3H2,1-2H3,(H,24,25,27)

InChI Key

JHJWKWSQCDWNNV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15121660

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

467.57

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.601

Distribution Coefficient, logD

5.494

Water Solubility, LogSw

-5.36

Polar Surface Area

80.864

Acid Dissociation Constant (pKa)

7.95

Base Dissociation Constant (pKb)

-1.14

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

13.00

L264-1285 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • Kinases
  • Proteases
  • Kinases

References: we are preparing a list of scientific research reports with L264-1285 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L264-1285?
Check Price and Availability of L264-1285, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L264-1285 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L264-1285
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L264-1285
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L264-1285 available by request